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Introduction
This series of articles provides regular surveillance of new
technologies which may impact on critical care. Several
countries have developed national horizon scanning systems
to identify and monitor new health technologies. There is
variation in how these centres gather information, but a
consistent set of high priority sources has been identified [1].
For the purposes of this article, the outputs of major health
technology assessment centres, national regulatory
authorities, and recognized scientific news sources (Table 1)
were systematically searched for developments relevant to
acute and critical care. This was combined with a manual
medical literature search, along key editorial themes
subjectively selected for this issue.
Point-of-care diagnostics and ultra-rapid
laboratory testing
Point-of-care testing is a major emerging theme throughout
the health sector, encompassing both new diagnoses and
monitoring of known diseases and their treatment. Areas of
research range from the potentially lucrative markets for
outpatient, ‘office’-based and patient self-testing, through to
in-hospital diagnostics, which include both rapid access
analysis of traditionally laboratory bound diagnostics and
direct patient imaging. Both aspects are particularly relevant
to critical care clinicians, who rely on time sensitive diagnosis
and treatment in a hyper-acute setting. An example of bedside
imaging in cardiac assessment has already been cited in the
first article of the present series [2]. Sample analysis,
meanwhile, is rapidly developing to encompass bedside
biochemical markers, physiological homeostasis monitoring,
and novel ultra-rapid forms of infectious disease diagnosis.
B-type natriuretic peptide can be a rapid and effective marker
of ventricular strain and heart failure [3], and can now be
measured using a point-of-care diagnostic panel (Triage BNP
Test; Biosite Inc., San Diego, CA, USA). Similar current and
forthcoming technologies include rapid access D-dimer
assays for diagnosis of pulmonary embolism as part of a
structured point-of-care algorithm [4] and unpublished early
developments in stroke diagnostics. Validation and clinical
trials of these technologies have taken place primarily in the
emergency department setting, but heart failure,
cerebrovascular accident and pulmonary embolism are all of
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added significance in the intensive care unit (ICU) as both
primary and acquired conditions. Rapid bedside diagnosis of
such conditions with minimal need for intrahospital transport
may be of great potential benefit to intensivists.
The importance of tight glucose control in sepsis is
becoming well established [5], although work continues on
refining the target range, with a study of 4,000 patients now
in progress (Normoglycaemia in Intensive CarE study,
ANZICS, commencing 2004). The first major prospective
study of tight glucose control in sepsis introduced a novel
algorithm requiring frequent measurements [6], which raised
concerns over patient safety and resource utilization in
general ICUs. Point-of-care ‘stick’ glucose testing is already
prevalent, but technology now exists for continuous in vivo
glucose monitoring, which, although intended for ambulatory
use, could improve accuracy in the acute setting. A
subcutaneous interstitial glucose sensor system (Continuous
Glucose Monitoring System; Medtronic MiniMed, Inc.,
Northridge, CA, USA) was tested against clamp controlled
hypoglycaemic and hyperglycaemic excursions in volunteers
[7]; it was shown to be closely correlated with reference
analyzer results (r2 = 0.91; P < 0.001) and highly responsive
(half-time 4.0 ± 1.0 min). Similarly, another device (Glucoday;
A. Menarini Diagnostics, Florence, Italy), utilizing a 15–100 µl
micropump and a biosensor coupled with microdialysis to
give a claimed response time of 2 min, will reach European
markets this year. Such devices may be incorporated into
manual algorithms, or they may potentially open the way to
automated closed-loop glucose control.
Microbiological diagnosis within clinical laboratories has
been advancing apace [8]. Polymerase chain reaction
technology is well established, but progressive refinements
have made possible the rapid and near real-time diagnosis of
current, novel, or newly relevant pathogens, including HIV
and SARS (severe acute respiratory syndrome). Techniques
initially aimed at viruses because of their manageable size
can now also be applied to bacteria and can be used for
broad, simultaneous screening of multiple pathogens
(Pneumoplex, Prodesse, Milwaukee, WI, USA). Further
refinements in microarrays and microfluidics are anticipated
to bring handhand and point-of-care systems into use in the
near future.
Point-of-care and rapid laboratory based technologies will
soon be able to elicit not only pathogen identity but also
patterns of drug resistance. Developments include the use of
adenylate kinase assay for accelerated laboratory based
identification of drug-resistant bacteria, including methicillin-
resistant Staphylococcus aureus and vancomycin-resistant
enterococci (BacLite, Acolyte Biomedica, Salisbury, UK;
http://www.acolytebiomedica.com/tech.htm).
Point-of-care testing within emergency and critical care areas
is likely to develop rapidly in the next 5 years, but it will bring
complications relating to quality control, medicolegal liability,
certificated training for ICU and other nonlaboratory staff,
increased cost, and territoriality issues.
Finally, other bedside technologies that have recently been
assessed include the use of handheld ultrasound devices to
detect occult pneumothoraces, which have been shown to
have a higher sensitivity than chest radiography (48.8%
versus 20.9%) against a computed tomography standard [9].
Preliminary investigations suggest that handheld infrared
Table 1
Agencies and information scources scanned for health technology assessment related data (2004)
Agency/information source Home page
The European Agency for the Evaluation of Medicinal Products (EMEA) http://www.emea.eu.int/
US Food and Drug Administration (FDA) http://www.fda.gov/
UK Medicines and Healthcare Products Regulatory Agency (MHRA) http://www.mhra.gov.uk/
National Horizon Scanning Centre, University of Birmingham, UK http://www.pcpoh.bham.ac.uk/publichealth/horizon/
Canadian Coordinating Office for Health Technology Assessment (CCOHTA) http://www.ccohta.ca/entry_e.html
Swedish Early Warning System: SBU ALERT http://www.sbu.se/www/index.asp
The European Information Network on New and Changing Health  http://www.publichealth.bham.ac.uk/euroscan/Default.htm
Technologies (EuroScan)
Current Controlled Trials (London) http://www.controlled-trials.com/
Centre for Reviews and Dissemination, University of York, UK http://www.york.ac.uk/inst/crd/
EurekAlert (online portal) http://www.eurekalert.org/
New Scientist  http://www.newscientist.com/home.ns
Reuters Health http://www.reutershealth.com/en/index.html14
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pupillometry may be of clinical use in detecting midline
cerebral shift in head injury patients [10].
More procedure orientated assistance may become available
from near-infrared technology, which has been piloted in a
computerized bedside visualization device to aid venous
cannulation [11]. Applicability to central venous cannulation
has not been explored.
Infection and sepsis
Acquired bloodstream infection (BSI) in the ICU is a serious
complication. A study of ICU patients in Calgary [12] demon-
strated crude death rates of 45% among patients with ICU-
acquired BSI, as compared with 21% in those without
(P < 0.0001).
S aureus was isolated in 18% of cases in the study cited
above. In this context, the development of an antistaphylo-
coccal vaccine (StaphVAX; Nabi Pharmaceuticals, Boca
Raton, FL, USA) represents a promising new health
technology [13]. StaphVAX is currently in phase III trials for
end-stage renal disease, but phase II trials are under way in
postoperative and long hospital stay patients.
Health technology assessment encompasses the best use
of current health care devices as well as emerging
technologies. Medical devices represent a prime infection
hazard, and US Centers for Disease Control and Prevention
guidelines [14] cover the safe use of intravascular devices
to minimize acquired BSI. However more recent work
demonstrates that the incidence of catheter-related BSI
may be significantly reduced by adding a further device –
needle-free, disinfectable connectors instead of three-way
stopcocks – to the existing recommendations (0.7
infections/1000 days versus 5.0 infections/1000 days of
catheter use; P < 0.03) [15].
Clinical management of sepsis is normally outside the remit
of this section of the journal. However, it is noteworthy that
new mechanical technology has been applied to the direct
treatment of sepsis rather than to cardiovascular or tissue
perfusion monitoring. A recent European multicentre open
randomized phase II trial [16] investigated the use of the
Endotoxin Adsorber system EN500 (Fresenius, Bad
Homburg, Germany) in 145 patients with severe sepsis or
septic shock due to suspected Gram-negative infection. The
study demonstrated a trend toward reduced ICU stay and
more rapid reduction in lipopolysaccharide levels, but it failed
to show any difference in outcome.
Information technology
Certain developments in this sector are pertinent to critical
care. ISABEL is a web-based, diagnostic decision support
tool intended to provide diagnosis reminders and minimize
missed diagnosis of critical disease processes. It is currently
in use in several UK and overseas hospitals, with
development supported by UK Department of Health funding
followed by a commercial launch [17].
The methodology is novel; a commercial artificial intelligence
inference engine (Autonomy, Cambridge, UK) is used to
extract and structure information from standard paediatric
textbooks, and to generate diagnostic reminders from this
knowledge base in response to unstructured free text clinical
information. The software has been under development for
some time and was reviewed in this journal in 2002 [18], but
it is now being modified to encompass adult critical illness. A
review of decision support systems by the UK National
Institute of Clinical Excellence is pending.
There are political and medicolegal implications. The ISABEL
project was initially set up on a charitable basis by the
parents of a child who survived a prolonged stay in paediatric
intensive care after a missed diagnosis of necrotizing fasciitis.
Although the system is as yet little known among adult
intensivists, its technology is innovative and its proposed
status as an ‘online second opinion’ may give it, together with
similar expert systems, a powerful consumerist resonance
with patients, carers and managers. The UK National Institute
of Clinical Excellence findings should be monitored with
interest by critical care providers.
More broadly, the UK health service is currently in the grip of
a globally unprecedented large-scale National Project for IT
(NPfIT) [19]. Structured as a series of private finance
initiatives, this ambitious programme will ultimately see in a
host of regionally standardized patient information systems,
image storage, and networked monitoring and audit systems,
linked to a national electronic patient record ‘spine’. There
are already concerns about timescale, feasibility and funding.
Broader concern is growing about catastrophic and
unpredictable ‘emergent behaviour’ in massively
interconnected information technology (IT) systems, which
are rapidly becoming too complex to test or accurately model
[20]. Emergent behaviour in complex systems has already
been explored in popular fictional media, in which predicted
outcomes are spectacular but somewhat discouraging [21];
however, even without quite such an apocalyptic scenario,
we may well see a rising incidence of total system failures
due to unpredictable nonlinear behaviour – that is, major
collapses triggered by small unforeseen causes. In the light
of recent North American power outages and destructive
computer failures in the UK social service and tax systems,
emergent behavour must now be considered a clear and
present threat to our increasingly networked health services
and their supporting infrastructure. Levels of concern are such
that the UK Government is funding a £10 million research
programme into IT complexity and catastrophic failures.
How much of this is relevant to critical care or to other
countries? First, ICUs provide complex, time-sensitive care to
highly dependent patients. They therefore require the15
successful convergence of multiple hospital systems, which
makes them uniquely vulnerable to the consequences of
system failures, whether in diagnostics, supplies, information
flow, or indeed electrical power. Second, the currently stated
UK NPfIT vision is that all ICU subsystems, including
networked monitoring, telemetry and audit systems, will
eventually be integrated into NPfIT, with control over
equipment selection and data collection handed to the
regional private sector consortia and to national audit bodies.
Clinician engagement and choice may not feature highly on
the agenda, and there are clear concerns over the future of
independent research and audit. Finally, clinicians from other
countries would be well advised to follow such developments
because the UK is not unique in its desire to radically
modernize and standardize health IT, starting with a drive
toward electronic patient records. In April 2004, President
Bush issued an executive order calling for US national
implementation of electronic medical records within 10 years,
from a current baseline of 19% implementation. In a series of
presidential speeches he went on to further define health
care objectives substantially similar to the UK NPfIT agenda
[22].
Therefore, this represents another area in which political and
technological developments outside the ICU may have a
direct impact on clinical practice and patient safety, and
intensivists are strongly recommended to consult early and
engage with those driving their local and national health
economy.
Conclusion
A variety of emerging technologies are examined here. Very
few of these are designed or marketed to be specific to
intensive care, and few are traditional ‘devices’ that can be
physically handled or attached to a patient. However, critical
care is a distillation of acute hospital practice, and any health
care technology that has an impact on diagnosis, monitoring,
and management of acute conditions will be of heightened
importance in the clinical pressure cooker of intensive care.
Point-of-care testing, accelerated microbiological
diagnostics, decision support systems and networked IT
systems are all key developments that will exert an impact on
future critical care practice.
Competing interests
The author(s) declare that they have no competing interests.
References
1. Douw K, Vondeling H, Eskildsen D, Simpson S: Use of the Inter-
net in scanning the horizon for new and emerging health
technologies: a survey of agencies involved in horizon scan-
ning. J Med Internet Res 2003, 5:e6.
2. Chapman M, Gattas D, Suntharalingam G: Innovations in tech-
nology for critical care medicine. Crit Care 2004, 8:74-76.
3. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R,
Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS: Utility of B-
type natriuretic peptide in the diagnosis of congestive heart
failure in an urgent-care setting. J Am Coll Cardiol 2001, 37:
379-385.
4. Kline JA, Webb WB, Jones AE, Hernandez-Nino J: Impact of a
rapid rule-out protocol for pulmonary embolism on the rate of
screening, missed cases, and pulmonary vascular imaging in
an urban US emergency department. Ann Emerg Med 2004,
44:490-502.
5. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen
J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, et al.: Sur-
viving sepsis campaign guidelines for management of severe
sepsis and septic shock. Crit Care Med 2004, 32:858-873.
6. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyn-
inckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouil-
lon R: Intensive insulin therapy in critically ill patients. N Engl J
Med 2001, 345:1359-1367.
7. Steil GM, Rebrin K, Mastrototaro J, Bernaba B, Saad MF: Deter-
mination of plasma glucose during rapid glucose excursions
with a subcutaneous glucose sensor. Diabetes Technol Ther
2003, 5:27-31.
8. Robertson BH, Nicholson JK: New microbiology tools for public
health and their implications. Annu Rev Public Health 2005,
26:07.1-07.22.
9. Kirkpatrick AW, Sirois M, Laupland KB, Liu D, Rowan K, Ball CG,
Hameed SM, Brown R, Simons R, Dulchavsky SA, et al.: Hand-
held thoracic sonography for detecting post-traumatic pneu-
mothoraces: the Extended Focused Assessment with
Sonography for Trauma (EFAST). J Trauma 2004, 57:288-295.
10. Taylor WR, Chen JW, Meltzer H, Gennarelli TA, Kelbch C, Knowl-
ton S, Richardson J, Lutch MJ, Farin A, Hults KN, et al.: Quantita-
tive pupillometry, a new technology: normative data and
preliminary observations in patients with acute head injury.
Technical note. J Neurosurg 2003, 98:205-213.
11. Biever C: Vein camera keeps injections on target. New Scien-
tist 2004, 6 October. [http://www.newscientist.com/
article.ns?id=dn6497] (last accessed 6 January 2005).
12. Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB:
Intensive-care-unit-acquired bloodstream infections in a
regional critically ill population. J Hosp Infect 2004, 58:137-
145.
13. National Horizon Scanning Centre: New and Emerging Technol-
ogy Briefing: StaphVAX for the Prevention of Staphylococcus
aureus Infections in End Stage Renal Disease. Birmingham, UK:
National Horizon Scanning Centre, University of Birmingham;
2004. [http://www.pcpoh.bham.ac.uk/publichealth/horizon/PDF_files/
2004reports/StaphVax.pdf] (last accessed 6 January 2005).
14. O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard
SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML,
et al.: Guidelines for the prevention of intravascular catheter-
related infections. MMWR Recomm Rep 2002,  51:1-26.
[http://www.cdc.gov/mmwr/PDF/RR/RR5110.pdf] (last accessed
6 January 2005).
15. Yebenes JC, Vidaur L, Serra-Prat M, Sirvent JM, Batlle J, Motje M,
Bonet A, Palomar M: Prevention of catheter-related blood-
stream infection in critically ill patients using a disinfectable,
needle-free connector: a randomized controlled trial. Am J
Infect Control 2004, 32:291-295.
16. Reinhart K, Meier-Hellmann A, Beale R, Forst H, Boehm D,
Willatts S, Rothe KF, Adolph M, Hoffmann JE, Boehme M, et al.:
Open randomized phase II trial of an extracorporeal endo-
toxin adsorber in suspected Gram-negative sepsis. Crit Care
Med 2004, 32:1662-1668.
17. Isabel homepage [http://www.isabel.org.uk/index.jsp] (last
accessed 6 January 2005).
18. Thomas NJ: Isabel. Crit Care 2002, 7:99-100.
19. National Programme for IT (NPfIT) in the NHS homepage
[http://www.npfit.nhs.uk/] (last accessed 6 January 2005).
20. Graham-Rowe D: Sprawling systems teeter on IT chaos. New
Scientist 2004, 27 November. [http://www.newscientist.com/
article.ns?id=dn6706] (last accessed 6 January 2005).
21. Mostow J (Director): Terminator 3: Rise of the Machines. Munich:
Intermedia Films; 2003.
22. The White House: President Bush Touts Benefits of Health Care
Information Technology. Washington, DC: Office of the White
House Press Secretary; 27 April 27 2004. [http://www.white-
house.gov/news/releases/2004/04/20040427-5.html] (last
accessed 6 January 2005).
Available online http://ccforum.com/content/9/1/12